Merit Financial Group LLC Has $809,000 Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Merit Financial Group LLC raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 193.7% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,068 shares of the biotechnology company’s stock after acquiring an additional 2,683 shares during the quarter. Merit Financial Group LLC’s holdings in Axon Enterprise were worth $809,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in AXON. Capital International Investors grew its stake in shares of Axon Enterprise by 605.2% during the 1st quarter. Capital International Investors now owns 2,660,634 shares of the biotechnology company’s stock worth $366,449,000 after acquiring an additional 2,283,343 shares in the last quarter. Sands Capital Management LLC grew its stake in shares of Axon Enterprise by 101.6% during the 2nd quarter. Sands Capital Management LLC now owns 1,993,126 shares of the biotechnology company’s stock worth $388,899,000 after acquiring an additional 1,004,556 shares in the last quarter. BlackRock Inc. grew its stake in shares of Axon Enterprise by 11.7% during the 1st quarter. BlackRock Inc. now owns 8,329,479 shares of the biotechnology company’s stock worth $1,872,883,000 after acquiring an additional 870,481 shares in the last quarter. Norges Bank bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $102,920,000. Finally, Geode Capital Management LLC grew its stake in shares of Axon Enterprise by 57.3% during the 2nd quarter. Geode Capital Management LLC now owns 1,583,100 shares of the biotechnology company’s stock worth $308,281,000 after acquiring an additional 576,420 shares in the last quarter. 76.52% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. TheStreet raised Axon Enterprise from a “c” rating to a “b” rating in a report on Tuesday, November 7th. Raymond James increased their price objective on Axon Enterprise from $223.00 to $233.00 and gave the company an “outperform” rating in a report on Wednesday, November 8th. Needham & Company LLC reissued a “buy” rating and issued a $240.00 price objective on shares of Axon Enterprise in a report on Friday. Finally, Barclays increased their price objective on Axon Enterprise from $247.00 to $296.00 and gave the company an “overweight” rating in a report on Tuesday, January 2nd. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $250.82.

View Our Latest Stock Analysis on Axon Enterprise

Insider Activity

In other news, insider Jeffrey C. Kunins sold 41,167 shares of the business’s stock in a transaction dated Friday, November 10th. The shares were sold at an average price of $217.33, for a total value of $8,946,824.11. Following the completion of the sale, the insider now owns 236,655 shares of the company’s stock, valued at $51,432,231.15. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, insider Jeffrey C. Kunins sold 41,167 shares of the business’s stock in a transaction dated Friday, November 10th. The shares were sold at an average price of $217.33, for a total value of $8,946,824.11. Following the completion of the sale, the insider now owns 236,655 shares of the company’s stock, valued at $51,432,231.15. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 260 shares of the business’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $230.38, for a total value of $59,898.80. Following the completion of the transaction, the president now directly owns 356,229 shares of the company’s stock, valued at approximately $82,068,037.02. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 85,343 shares of company stock valued at $19,964,734. 6.10% of the stock is owned by company insiders.

Axon Enterprise Trading Up 1.7 %

Shares of Axon Enterprise stock opened at $256.99 on Friday. Axon Enterprise, Inc. has a 1 year low of $168.30 and a 1 year high of $262.95. The company has a debt-to-equity ratio of 0.44, a current ratio of 3.15 and a quick ratio of 2.78. The company has a market capitalization of $19.26 billion, a price-to-earnings ratio of 131.79 and a beta of 0.90. The business has a fifty day simple moving average of $248.43 and a two-hundred day simple moving average of $219.80.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its earnings results on Tuesday, November 7th. The biotechnology company reported $0.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.31. The company had revenue of $413.60 million during the quarter, compared to analysts’ expectations of $393.77 million. Axon Enterprise had a net margin of 9.96% and a return on equity of 12.63%. Research analysts forecast that Axon Enterprise, Inc. will post 2.29 EPS for the current year.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.